Small Molecule Cyclotriazadisulfonamide Abrogates the Upregulation of the Human Receptors CD4 and 4-1BB and Suppresses In Vitro Activation and Proliferation of T Lymphocytes.

Front Immunol · 2021 · PMC8097030 · PMID 33968048

Europe PMC DOI

hedged sentence

0.0025

closest p · 0.0× alpha

0.0025

boldest claim

The sentences

highly significantp = 0.0025actually significant

In sharp contrast, CADA nearly completely blocked the upregulation of 4‐1BB in all samples (89 ± 4% and 79 ± 3% reduction in MFI for CD3/CD8 and PHA, respectively), which was highly significant (p = 0.0025 and 0.0011, respectively; paired t-test).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.